India's 2026 AI Rules Mandate 3-Hour Takedown for Deepfakes but Overlook Consent and Victim Support

Health Ministry Amends Drugs Rules, 1945: New Debarment Power for Fake Data Cases

The Health Ministry has strengthened the Drugs Rules, 1945 to penalize applicants who submit fake data for drug approvals. Previously, only rejection/cancellation was possible; now licensing authorities can debar entities from filing new applications for a period, with show-cause notice and appeal provisions. This is crucial for exam questions on regulatory frameworks, pharmaceutical governance, and the Drugs & Cosmetics Act.

India's AI Pipeline: 43% Women STEM Graduates, Only 10% in Leadership – Need for Inclusive AI

India's AI ambition faces a hidden gender crisis: women drop from 43% of STEM graduates to just 10% of senior AI leadership. This pipeline leakage, driven by social barriers and digital divide, risks automating existing inequalities. For exam aspirants, this article provides critical data on gender disparity in tech and the imperative for inclusive AI development.

VP Launches India Valve Registry for Heart Valve Disease Research; TN Reports 2,590 Valve Replacements in 20 Months

The Vice-President launched the India Valve Registry, a first-of-its-kind clinician-led platform to collect real-world data on valvular heart disease and interventions in India. The registry will generate India-specific evidence to improve patient care, while Tamil Nadu's CMCHIS data reveals 2,590 valve replacements in 20 months, highlighting the burden of rheumatic heart disease and the success of state-led healthcare.

India Ranks 3rd in Research Volume, 19th in h-index; NIRF's 30% Weightage Under Scrutiny

India’s research output is booming on paper—1.6 million Scopus-indexed papers in five years and a 4x jump in university patent filings—but global impact is weak: India ranks only 19th by h-index and 3rd in retractions. The article exposes how NIRF’s 30% weightage to raw research output and a cash-incentive culture have created a ‘paper fortress’ rather than real-world knowledge power.

FSSAI Initiates 3 Cases Against Nestlé India Over IMS Act, Biotin Levels

FSSAI has initiated three separate cases against Nestlé India for alleged violations of the IMS Act and food safety regulations related to infant formula promotional claims and biotin content. This action reinforces India's strict stance on protecting breastfeeding practices and regulating infant nutrition marketing. For exams, this links to the FSS Act, IMS Act, and regulatory enforcement mechanisms.

MeitY Summons Meta Global Team Over Algorithmic Bias; Parliamentary Panel to Question

Government summons Meta's global team to clarify algorithmic bias and role in public order after MeitY rejects technical glitch explanation. Parliamentary panel will also question the company. This highlights growing regulatory scrutiny on social media algorithms and their societal impact.

NOTTO Reports 20,000+ Transplants in 2025, Launches Portal and Swap Guidelines

NOTTO released 2025 data showing over 20,000 transplants, persistent gender disparity in organ donation (68% female donors vs 78% male recipients), and launched a new digital portal to enhance transparency. New swap transplantation guidelines aim to expand matching beyond single hospitals, but legal recognition under THOTA is still pending.

AI in Education: 11% of Papers Contain AI Text, Shift from Banning to Guided Use Needed

India's education system must move from fear-led restriction to structured enablement of AI. With 11% of student papers containing AI language, institutions need to define permitted use, require disclosure, and assess process over output. The article outlines two parallel strategies: using AI to teach better and teaching students to use AI better.